Education
About Us
Working with TipRanks
Follow Us
BICO Group AB Class B (CLLKF)
OTHER OTC:CLLKF
CLLKF Stock Chart & Stats
$1.98
$0.10(3.47%)
At close: 4:00 PM EST
$1.98
$0.10(3.47%)
Day’s Range― - ―
52-Week Range$1.69 - $4.33
Previous CloseN/A
Volume500.00
Average Volume (3M)167.00
Market Cap
$138.27M
Enterprise Value$1.44B
Total Cash (Recent Filing)$1.28B
Total Debt (Recent Filing)$1.50B
Price to Earnings (P/E)―
Beta0.19
Next Earnings
Apr 29, 2026EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding69,074,900
10 Day Avg. Volume250
30 Day Avg. Volume167
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.85
Price to Sales (P/S)0.99
P/FCF Ratio26.97
Enterprise Value/Market Cap10.39
Enterprise Value/Revenue0.93
Enterprise Value/Gross Profit2.05
Enterprise Value/Ebitda-1.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.25
Revenue Forecast (FY)$176.96M
Bulls Say, Bears Say
Bulls Say
Improving Cash GenerationSustained improvement to positive operating cash flow (2023–2025) and FY free cash flow turning positive in 2024–2025 creates a more durable liquidity runway. This improves capacity to fund R&D, consumables inventory and service operations, reducing reliance on external financing over the medium term.
Strong Lab Automation DemandA 35% organic rebound in Lab Automation signals structurally stronger demand for automation and software (e.g., Green Button Go). Sustainable growth in this segment supports recurring software and consumable revenue, improves unit economics, and underpins scalable margin recovery if execution continues.
Material Cash Strengthening From DivestmentsProceeds of SEK 740m from strategic divestments materially bolster the cash reserve and created a net cash position, enhancing near-term liquidity and optionality. This allows management to de-risk the balance sheet, prioritize core product investment, and pursue targeted M&A or restructuring without immediate external funding.
Bears Say
Multi-year Revenue ContractionThree consecutive years of revenue decline indicate persistent demand or portfolio challenges. Prolonged top-line contraction reduces scale, weakens pricing power, compresses gross margins, and limits the company’s ability to invest consistently in product development and sales capacity, impeding sustainable recovery.
Large Impairments And Earnings VolatilityA SEK 1,036m impairment reflects write-downs of previously capitalized assets or acquisitions and signals lower-than-expected returns on investments. Such non‑cash charges erode equity, complicate performance comparisons, and highlight execution or portfolio fit issues that can persistently depress reported profitability.
Weak Cash Flow Relative To DebtEven with improved cash generation, operating cash covers only a small fraction of debt and FCF plunged in 2025. Limited cash flow coverage and worsening leverage reduce financial flexibility, raise refinancing risk, and constrain sustained investment in R&D and commercialization over the medium term.
BICO Group AB Class B News
CLLKF FAQ
What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was $1.69 and its highest was $4.33 in the past 12 months.
What is BICO Group AB Class B’s market cap?
BICO Group AB Class B’s market cap is $138.27M.
When is BICO Group AB Class B’s upcoming earnings report date?
BICO Group AB Class B’s upcoming earnings report date is Apr 29, 2026 which is in 53 days.
How were BICO Group AB Class B’s earnings last quarter?
BICO Group AB Class B released its earnings results on Feb 18, 2026. The company reported -$0.089 earnings per share for the quarter, missing the consensus estimate of -$0.051 by -$0.038.
Is BICO Group AB Class B overvalued?
According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued.
Does BICO Group AB Class B pay dividends?
BICO Group AB Class B does not currently pay dividends.
What is BICO Group AB Class B’s EPS estimate?
BICO Group AB Class B’s EPS estimate is -0.13.
How many shares outstanding does BICO Group AB Class B have?
BICO Group AB Class B has 69,074,900 shares outstanding.
What happened to BICO Group AB Class B’s price movement after its last earnings report?
BICO Group AB Class B reported an EPS of -$0.089 in its last earnings report, missing expectations of -$0.051. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BICO Group AB Class B?
Currently, no hedge funds are holding shares in CLLKF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BICO Group AB Class B
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
CLLKF Company Deck
CLLKF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presents a mixed picture with strong growth in Lab Automation and significant orders from a global pharma company. However, impairments and macroeconomic challenges, including negative cash flow from operations, present notable challenges.View all CLLKF earnings summariesTechnical Analysis
CellaVision AB
―
Senzime AB
―
Bactiguard Holding AB
―
C-Rad AB Class B
―
Sedana Medical AB
―
Ownership Overview
―
Insiders
0.02% Mutual Funds
1.56% Other Institutional Investors
96.16% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---